Moreover, these histological alterations were supported by the level of proteins associated with inflammation (TNFα and p65) and fibrosis (COL1A1), which were overexpressed in NASH mice and reduced after ginkgetin treatment (Figure 2B). The gene discussed is COL1A1; the disease is metabolic dysfunction-associated steatohepatitis.